Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-26-051663
Filing Date
2026-02-13
Accepted
2026-02-13 16:50:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10407
  Complete submission text file 0001193125-26-051663.txt   12346
Mailing Address 25 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 25 HARTWELL AVENUE LEXINGTON MA 02421 978-349-3200
RAPID MICRO BIOSYSTEMS, INC. (Subject) CIK: 0001380106 (see all company filings)

EIN.: 208121647 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92824 | Film No.: 26634099
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address P.O. BOX 656, EAST WING, TRAFALGAR COURT LES BANQUES ST PETER PORT Guernsey
Business Address P.O. BOX 656, EAST WING, TRAFALGAR COURT LES BANQUES ST PETER PORT Guernsey 44 1481 749 714
Endeavour Medtech Growth II LP (Filed by) CIK: 0001873032 (see all company filings)

EIN.: 981530409 | State of Incorp.: Y7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A